175 related articles for article (PubMed ID: 20965738)
1. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.
Scanio MJ; Shi L; Drizin I; Gregg RJ; Atkinson RN; Thomas JB; Johnson MS; Chapman ML; Liu D; Krambis MJ; Liu Y; Shieh CC; Zhang X; Simler GH; Joshi S; Honore P; Marsh KC; Knox A; Werness S; Antonio B; Krafte DS; Jarvis MF; Faltynek CR; Marron BE; Kort ME
Bioorg Med Chem; 2010 Nov; 18(22):7816-25. PubMed ID: 20965738
[TBL] [Abstract][Full Text] [Related]
2. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
[TBL] [Abstract][Full Text] [Related]
3. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
[TBL] [Abstract][Full Text] [Related]
5. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel class of biphenyl pyrazole sodium channel blockers for treatment of neuropathic pain.
Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Eid R; Fisher MH; Parsons WH; Wyvratt MJ; Lyons KA; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Weber A; Duffy JL
Bioorg Med Chem Lett; 2010 Dec; 20(24):7479-82. PubMed ID: 21106456
[TBL] [Abstract][Full Text] [Related]
7. Functional tetrodotoxin-resistant Na(+) channels are expressed presynaptically in rat dorsal root ganglia neurons.
Medvedeva YV; Kim MS; Schnizler K; Usachev YM
Neuroscience; 2009 Mar; 159(2):559-69. PubMed ID: 19162133
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and functional profiles of voltage-gated Na(+) channels in injured and non-injured DRG neurons in the SNI model of neuropathic pain.
Berta T; Poirot O; Pertin M; Ji RR; Kellenberger S; Decosterd I
Mol Cell Neurosci; 2008 Feb; 37(2):196-208. PubMed ID: 17964804
[TBL] [Abstract][Full Text] [Related]
9. Reversal of neuropathic pain by alpha-hydroxyphenylamide: a novel sodium channel antagonist.
Ko SH; Jochnowitz N; Lenkowski PW; Batts TW; Davis GC; Martin WJ; Brown ML; Patel MK
Neuropharmacology; 2006 Jun; 50(7):865-73. PubMed ID: 16464480
[TBL] [Abstract][Full Text] [Related]
10. Substituted biaryl pyrazoles as sodium channel blockers.
Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
Bioorg Med Chem Lett; 2010 Sep; 20(18):5480-3. PubMed ID: 20709545
[TBL] [Abstract][Full Text] [Related]
11. Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain.
Hoyt SB; London C; Ok H; Gonzalez E; Duffy JL; Abbadie C; Dean B; Felix JP; Garcia ML; Jochnowitz N; Karanam BV; Li X; Lyons KA; McGowan E; Macintyre DE; Martin WJ; Priest BT; Smith MM; Tschirret-Guth R; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2007 Nov; 17(22):6172-7. PubMed ID: 17889534
[TBL] [Abstract][Full Text] [Related]
12. Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.
Kort ME; Atkinson RN; Thomas JB; Drizin I; Johnson MS; Secrest MA; Gregg RJ; Scanio MJ; Shi L; Hakeem AH; Matulenko MA; Chapman ML; Krambis MJ; Liu D; Shieh CC; Zhang X; Simler G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Werness S; Antonio B; Marsh KC; Faltynek CR; Krafte DS; Jarvis MF; Marron BE
Bioorg Med Chem Lett; 2010 Nov; 20(22):6812-5. PubMed ID: 20855211
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats.
Dong XW; Goregoaker S; Engler H; Zhou X; Mark L; Crona J; Terry R; Hunter J; Priestley T
Neuroscience; 2007 May; 146(2):812-21. PubMed ID: 17367951
[TBL] [Abstract][Full Text] [Related]
14. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23.
John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ
Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698
[TBL] [Abstract][Full Text] [Related]
15. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.
Leffler A; Reiprich A; Mohapatra DP; Nau C
J Pharmacol Exp Ther; 2007 Jan; 320(1):354-64. PubMed ID: 17005919
[TBL] [Abstract][Full Text] [Related]
16. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
Hoyt SB; London C; Gorin D; Wyvratt MJ; Fisher MH; Abbadie C; Felix JP; Garcia ML; Li X; Lyons KA; McGowan E; MacIntyre DE; Martin WJ; Priest BT; Ritter A; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4630-4. PubMed ID: 17588748
[TBL] [Abstract][Full Text] [Related]
18. Voltage-gated sodium channels: therapeutic targets for pain.
Dib-Hajj SD; Black JA; Waxman SG
Pain Med; 2009 Oct; 10(7):1260-9. PubMed ID: 19818036
[TBL] [Abstract][Full Text] [Related]
19. Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats.
Brochu RM; Dick IE; Tarpley JW; McGowan E; Gunner D; Herrington J; Shao PP; Ok D; Li C; Parsons WH; Stump GL; Regan CP; Lynch JJ; Lyons KA; McManus OB; Clark S; Ali Z; Kaczorowski GJ; Martin WJ; Priest BT
Mol Pharmacol; 2006 Mar; 69(3):823-32. PubMed ID: 16301337
[TBL] [Abstract][Full Text] [Related]
20. The effects of class Ic antiarrhythmics on tetrodotoxin-resistant Na+ currents in rat sensory neurons.
Osawa Y; Oda A; Iida H; Tanahashi S; Dohi S
Anesth Analg; 2004 Aug; 99(2):464-71, table of contents. PubMed ID: 15271726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
